People · Operator
Named in public records as an officer, director or promoter · active 2009–2016 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CVRx, Inc. | — | Other Health Care | Series C | $155.0M | $1.1B | 2013 |
| VytronUS Inc | — | Other Health Care | Series B | $91.1M | $664.6M | 2009 |
| Anulex Technologies Inc | — | Biotechnology | Series B | $32.3M | $724.8M | 2010 |
A. Jay Graf at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside A. Jay Graf on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Nehra | 1 | 11 |
| Buzz Benson | 1 | 8 |
| Peter Justin Klein | 1 | 7 |
| Roy Tanaka | 1 | 6 |
| Mike Sherman | 1 | 6 |
| Mudit K. Jain | 1 | 4 |
| Timothy Miller | 1 | 4 |
| John Pavlidis | 1 | 4 |
| Dale Spencer | 1 | 3 |
| Ali Jay Behbahani | 1 | 3 |
| John Maroney | 1 | 3 |
| Dave Stassen | 1 | 3 |
| Jay Graf | 1 | 2 |
| Ali M. Behbahani | 1 | 2 |
| Doug Roeder | 1 | 2 |
| John M. Nehra | 1 | 2 |
| Matt Meyer | 1 | 2 |
| Michael Pederson | 1 | 2 |
| John Jay Nehra | 1 | 2 |
| Josep Ll Sanfeliu | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.